VG Health Expands AI-Powered Healthcare Advertising with CMS-Enriched VoiceAlike® AI, New Audience Intelligence Tools and HCP Targeting

ViralGains, Inc., the leading marketing platform specializing in zero-party data and AI-powered audience-building solutions, today announced significant enhancements to VG Health, including the integration of Centers for Medicare & Medicaid Services (CMS) data into its VoiceAlike® AI, the launch of VoiceAlike® Insights for deeper audience intelligence and expanded HCP targeting capabilities through key partnerships.

"Healthcare marketers are under increasing pressure to improve precision, efficiency and measurable outcomes while navigating a privacy-conscious environment," said ViralGains’ CEO, Tod Loofbourrow. "VG Health helps advertisers better understand the patients and providers they're reaching by using insights and strategy grounded in real consumer feedback."

VG Health has expanded its VoiceAlike® AI predictive modeling with anonymous, aggregated data from CMS, including Medicare and Medicaid claims, hospital data, hierarchical condition category (HCC) risk factors that provide insight into disease severity and patient risk and prescription data. Layered on CDC health signals already integrated into the model, these enhancements allow advertisers to reach patients more precisely across major disease categories, identify high-value and undertreated patient populations, prioritize patient groups with more severe disease states or potential gaps in treatment, and improve predictions of treatment and prescribing behavior without relying on personally identifiable information.

CMS data spans 30,000–42,000 ZIP codes, giving VoiceAlike® AI a geographic disease burden map that reflects where patients with conditions such as COPD, heart failure and rare diseases actually live and receive care. CMS Part D prescriber data, for example, reveals where branded biologics are already being prescribed and reimbursed, which enables pharma brands to prioritize markets where clinical infrastructure align with their therapy, and tailor messaging accordingly.

ViralGains also launched VoiceAlike® Insights, a new audience intelligence feature within the ViralGains Odyssey™ platform. The tool allows advertisers to analyze VoiceAlike® audiences across demographics, health conditions, psychographics, behavioral patterns, interests and media tendencies. Additionally, advertisers can compare a VoiceAlike® audience against a baseline population to surface where it over- or under-indexes across hundreds of attributes.

In a recent rare disease campaign, a pharma brand used zero-party data collected through in-ad surveys to segment 1.8M reached patients into three journey stages: symptomatic but undiagnosed, diagnosed but untreated and diagnosed and in treatment. VoiceAlike® Insights revealed that the diagnosed but untreated segment significantly over-indexed on financial hardship indicators, including food and housing insecurity and lack of health insurance. For a treatment costing tens of thousands of dollars annually, these insights showed affordability was the primary obstacle to treatment initiation, which enabled the brand to tailor messaging and patient support resources accordingly.

Through partnerships with PurpleLab, IQVIA and Swoop, VG Health now supports National Provider Identifier (NPI)-based HCP targeting, verification of HCP reach and engagement and patient outcome measurement including Script Lift, NBRx and Doctor Visits. This enables brands to create a connected view of omnichannel healthcare engagement and bridge patient and HCP strategies more intelligently.

VG Health enables advertisers to understand how people actually feel, respond and engage during campaigns. Its unique approach creates a more dynamic and explainable healthcare advertising intelligence layer. 

To learn more about VG Health, visit viralgains.com/vghealth.